- If the symptoms begin to increase, an anti-inflammatory or mast cell stabilizer agent should be added along with the beta2 agonist.
- In moderate cases of asthma, the primary medication used to control symptoms should be an inhaled corticosteroid or mast cell stabilizer.
- Beta2 agonist should be used as needed.
- Other underlying contributory factors should be treated.
- Patients should closely monitor their PEFR daily and record results.
- These patients should have a pulmonologist involved in their care when needed. [4]
| | | | | |